Details for New Drug Application (NDA): 204426
✉ Email this page to a colleague
The generic ingredient in TAYTULLA is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 204426
Tradename: | TAYTULLA |
Applicant: | Apil |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 204426
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAYTULLA | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 204426 | NDA | Allergan, Inc. | 0023-5862 | 0023-5862-29 | 1 BLISTER PACK in 1 CARTON (0023-5862-29) / 1 KIT in 1 BLISTER PACK |
TAYTULLA | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 204426 | NDA | Allergan, Inc. | 0023-5862 | 0023-5862-30 | 5 CARTON in 1 TRAY (0023-5862-30) / 1 BLISTER PACK in 1 CARTON (0023-5862-28) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 0.02MG;1MG | ||||
Approval Date: | Apr 19, 2013 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 204426
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apil | TAYTULLA | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 204426-001 | Apr 19, 2013 | ⤷ Subscribe | ⤷ Subscribe |
Apil | TAYTULLA | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 204426-001 | Apr 19, 2013 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription